Back to Agenda
Regulatory Affairs: Part 8: Post-NDA Submission and Approval
Session Chair(s)
Carol H. Danielson, DrPH, MS, RAC
President
Regulatory Advantage, LLC, United States
Kevin Daniel Healy, PhD
Senior Vice President Regulatory Affairs
Entrada Therapeutics, United States
Regulatory Affairs: Part 8: Post-NDA Submission and Approval
Have an account?